performed deep single‐cell RNA sequencing on immune cells from HCC patients and controls, identifying distinct subtypes and pathways, and demonstrated that inhibiting APOC1 can shift macrophages from the M2 to the M1 phenotype via the ferroptosis pathway, potentially improving the efficacy of anti‐PD1 immunotherapy in HCC. Here, APOC1 is linked to hepatocellular carcinoma.